Systematic, proactive monitoring of medical devices throughout the commercial lifecycle — transforming real-world field data into regulatory-grade safety intelligence
ABOUT CARELYFT PMS SERVICES
CareLyft's Post-Market Surveillance (PMS) Services provide medical device
manufacturers with a structured,
end-to-end capability to monitor, evaluate, and act on real-world device performance
data. With deep
regulatory expertise across 40+ markets, CareLyft ensures your devices remain safe,
effective, and compliant
— from first commercialisation through their entire operational lifetime.
Our PMS team combines experienced regulatory affairs
professionals, clinical specialists, and complaint
management experts to deliver a seamless, audit-ready surveillance programme — fully
aligned with EU MDR
2017/745, EU IVDR 2017/746, 21 CFR Part 803/806, ISO 13485, and applicable global
vigilance frameworks.
CareLyft's PMS programme is built on eight integrated service pillars, each designed
to address a critical
dimension of post-market oversight. Our services can be engaged individually or as a
fully managed, end-to-
end PMS programme tailored to your device portfolio and regulatory obligations.
A fully managed complaint handling
programme covering the complete complaint lifecycle — from first
receipt through thorough investigation to formal closure — in compliance
with ISO 13485 Clause
8.2.2, 21 CFR Part 820.198, and MDR Article 87 requirements.
Multi-channel complaint intake: phone, email, field service reports,
and eQMS portals
Robust tracking systems maintaining
product traceability across the supply chain and end-use
environment — aligned with UDI and post-market requirements.
Unique Device Identification (UDI) system setup and compliance — EU
EUDAMED, FDA
GUDID, and global databases
Lot/batch and serial number traceability across distribution tiers
Regulatory technical file updates from post-market findings
Expert technical review for product liability
08. Health Hazard Evaluation
Rigorous, structured Health Hazard
Evaluation (HHE) to assess the clinical impact of device defects,
failures, or non-conformities — providing the evidentiary basis for
informed reportability and recall
decisions.
HHE initiation triggered by complaints, audit findings, CAPA, or
vigilance events
Clinical risk assessment using ISO 14971 risk management principles
Reportability determination: serious injury, death, or malfunction
assessment
HHE documentation to regulatory submission standard (FDA, MDR,
Health Canada)
Medical and clinical expert review and sign-off coordination
HHE outcomes fed back into risk management files and PMS plans
REGULATORY FRAMEWORKS SUPPORTED
CareLyft's PMS team operates across
the following regulatory frameworks and standards:
EU MDR 2017/745
EU IVDR 2017/746
ISO 13485:2016
21 CFR Part 803 (FDA MDR)
21 CFR Part 806 (Recalls)
21 CFR Part 820 (QSR)
ISO 14971:2019
MEDDEV 2.12/1 Rev 8
Health Canada MDR
TGA (Australia)
MHLW / PMDA (Japan)
MDSAP
WHY CHOOSE CARELYFT FOR PMS
ISO 13485-certified PMS operations with End-to-End PMS
lifecycle management
Experienced Regulatory professionals with strong
regulatory expertise and domain knowledge
Audit-ready documentation and traceability at every step
Seamless eQMS and complaint system integration
Scalable solutions tailored to your business needs
Multi-market simultaneous vigilance submissions
Scalable — from single-product to full portfolio
management
Timely submissions and audit-ready processes
Transparent KPI reporting and real-time dashboards
High-quality, compliant documentation and reporting
DEVICE TYPES SUPPORTED
CareLyft's PMS Services support the full spectrum of medical device categories: